"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

Grommes C, Oxnard GR, Kris MG, Miller VA, Pao W, Holodny AI, Clarke JL, Lassman AB
Neuro Oncol. 2011 13 (12): 1364-9

PMID: 21865399 · PMCID: PMC3223088 · DOI:10.1093/neuonc/nor121

MeSH Terms (18)

Adult Aged Antineoplastic Agents Carcinoma, Non-Small-Cell Lung Central Nervous System Neoplasms ErbB Receptors Erlotinib Hydrochloride Female Follow-Up Studies Humans Lung Neoplasms Male Middle Aged Mutation Quinazolines Retrospective Studies Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links